HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

KB425796-C

structure in first source

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Polycyclic Compounds: 6
- Macrocyclic Compounds: 15
  - Cyclic Peptides: 530
    - Depsipeptides: 297
      - KB425796-C: 2
Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Cyclic Peptides: 530
    - Depsipeptides: 297
      - KB425796-C: 2

Experts

1.	Fujie, Akihiko: 2 articles (08/2013 - 08/2013)
2.	Inamura, Noriaki: 2 articles (08/2013 - 08/2013)
3.	Kai, Hirohito: 2 articles (08/2013 - 08/2013)
4.	Nakamura, Ikuko: 2 articles (08/2013 - 08/2013)
5.	Nitta, Kumiko: 2 articles (08/2013 - 08/2013)
6.	Watanabe, Masato: 2 articles (08/2013 - 08/2013)
7.	Yamashita, Midori: 2 articles (08/2013 - 08/2013)
8.	Yoshikawa, Koji: 2 articles (08/2013 - 08/2013)
9.	Ezaki, Masami: 1 article (08/2013)
10.	Hashimoto, Michizane: 1 article (08/2013)

Related Diseases

1.	Mycoses (Diseases, Fungus) 08/01/2013 - "KB425796-C can be a potential drug candidate for treating micafungin-resistant fungal infections. "
2.	Infections 08/01/2013 - "fumigatus infection, although non-treated mice survived for a maximum of only 6 days, the survival rate of micafungin-treated mice (0.1 mg kg(-1)) increased to 20%, while the survival rate of mice treated with a combination of micafungin (0.1 mg kg(-1)) and KB425796-C (32 mg kg(-1)) increased to 100% during the 31-day post-infection period. " 08/01/2013 - "Synergistic antifungal activity of KB425796-C in combination with micafungin against Aspergillus fumigatus and its efficacy in murine infection models."
3.	Aspergillosis 08/01/2013 - "Our findings suggest that KB425796-C is a good candidate for the treatment of aspergillosis in combination with micafungin. "

Related Drugs and Biologics

1.	Micafungin (FK463)